These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26616218)

  • 1. Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity.
    Yoon YK; Choon TS
    Arch Pharm (Weinheim); 2016 Jan; 349(1):1-8. PubMed ID: 26616218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.
    Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N
    Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
    Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
    Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
    Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
    J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.
    Tervo AJ; Suuronen T; Kyrylenko S; Kuusisto E; Kiviranta PH; Salminen A; Leppänen J; Poso A
    J Med Chem; 2006 Nov; 49(24):7239-41. PubMed ID: 17125277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1
    Han H; Li C; Li M; Yang L; Zhao S; Wang Z; Liu H; Liu D
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
    Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
    Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
    Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: An in silico and in vitro study.
    Sinha S; Patel S; Athar M; Vora J; Chhabria MT; Jha PC; Shrivastava N
    Int J Biol Macromol; 2019 Nov; 140():454-468. PubMed ID: 31404596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
    Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
    Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in inhibitors of sirtuin1/2: an update and perspective.
    Zhou Z; Ma T; Zhu Q; Xu Y; Zha X
    Future Med Chem; 2018 Apr; 10(8):907-934. PubMed ID: 29642711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of novel Indole-Based small molecules as sirtuin inhibitors with anticancer activities.
    Binarci B; Kilic EK; Dogan T; Cetin Atalay R; Kahraman DC; Nacak Baytas S
    Drug Dev Res; 2024 Nov; 85(7):e70008. PubMed ID: 39428864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.
    Loharch S; Chhabra S; Kumar A; Swarup S; Parkesh R
    Bioorg Chem; 2021 May; 110():104768. PubMed ID: 33676042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
    Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
    Neugebauer RC; Uchiechowska U; Meier R; Hruby H; Valkov V; Verdin E; Sippl W; Jung M
    J Med Chem; 2008 Mar; 51(5):1203-13. PubMed ID: 18269226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.
    Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M
    Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
    Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and binding free energy calculations of sirtuin inhibitors.
    Karaman B; Sippl W
    Eur J Med Chem; 2015 Mar; 93():584-98. PubMed ID: 25748123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.